 |
Amifostine |
|---|---|
| Trade Name | Ethyol |
| Orphan Indication | For the reduction of the incidence and severity of toxicities associated with cisplatin administration |
| USA Market Approval | USA |
| USA Designation Date | 1998-11-24 00:00:00 |
| Sponsor | Clinigen Group plc;Pitcairn House, Crown Square, DE14 2WW; |
